English

ONCOTELIC THERAPEUTICS, INC.

EDGAR

MATN Current report (8-K) · filed 2026-10-26

181 filing records in this dataset, filed from 1996-05-15 to 2026-10-26. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

250 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Revenue: 250000 USD Source

Operating margin

-337.43%

2026 Q2 · %

Exact inputs and evidence

Operating Income: -843565 USD Source
Revenue: 250000 USD Source

Operating cash flow

-100 thousand USD

2026 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -400000 USD Source
Operating Cash Flow: -300000 USD Source

Cash and cash equivalents: 409 thousand USD 2025-09-30 Source
Exact value

409000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 457 million shares 2026-06-30 Source
Exact value

457012796 shares

Reported share-count change

11.93% · 48.7 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

408292720 shares · 2025-06-30· Source
457012796 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

248 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Net income: -1047365 USD · 2025-07-01 – 2025-09-30 Source
Net income: 249300000 USD · 2025-01-01 – 2025-12-31 Source
Net income: -1068225 USD · 2025-01-01 – 2025-09-30 Source
Net income: -2193776 USD · 2026-01-01 – 2026-03-31 Source
Net income: 388147 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-1.51 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence

Operating cash flow: -600000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -293106 USD · 2025-01-01 – 2025-06-30 Source
Operating cash flow: -1400000 USD · 2025-01-01 – 2025-12-31 Source
Operating cash flow: -600000 USD · 2025-01-01 – 2025-09-30 Source
Operating cash flow: -300000 USD · 2026-01-01 – 2026-03-31 Source
Operating cash flow: -400000 USD · 2026-01-01 – 2026-06-30 Source
Operating cash flow: -300000 USD · 2026-01-01 – 2026-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-10-26.

Financial data available through: 2025-12-31.

Coverage by financial measure

Revenue: 2 of 11 periods available· newest 2023-12-31
Operating income: 11 of 11 periods available· newest 2025-12-31
Net income: 11 of 11 periods available· newest 2025-12-31
Operating cash flow: 11 of 11 periods available· newest 2025-12-31
Capital expenditure: 1 of 11 periods available· newest 2015-12-31
Total assets: 11 of 11 periods available· newest 2025-12-31
Total liabilities: 4 of 11 periods available· newest 2025-12-31
Current assets: 11 of 11 periods available· newest 2025-12-31
Current liabilities: 11 of 11 periods available· newest 2025-12-31
Cash and cash equivalents: 10 of 11 periods available· newest 2024-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2025-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Net income
+USD 253.82 million

Prior period

−USD 4.52 million

2024-01-01 – 2024-12-31
Current period

USD 249.3 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

249300000 − -4523932 = 253823932 USD

-4523932 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
249300000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · ONCOTELIC THERAPEUTICS, INC. · 2025-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Year-over-year change in Net income: 253823932 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: 249300000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315226037857/form10-q.htm#639003 Filing: 000149315226037857 Input fundies:NetIncome: -4523932 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315226016838/form10-k.htm#1799652 Filing: 000149315226016838
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 659,723

Prior period

−USD 740,277

2024-01-01 – 2024-12-31
Current period

−USD 1.4 million

2025-01-01 – 2025-12-31

Exact inputs and evidence

-1400000 − -740277 = -659723 USD

-740277 USD · 2024-01-01 – 2024-12-31
Inspect prior input Prior source
-1400000 USD · 2025-01-01 – 2025-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · ONCOTELIC THERAPEUTICS, INC. · 2025-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Year-over-year change in Operating cash flow: -659723 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -1400000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315226016838/form10-k.htm#2059648 Filing: 000149315226016838 Input fundies:OperatingCashFlow: -740277 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315226016838/form10-k.htm#1971522 Filing: 000149315226016838
The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue, Capital expenditure.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 70,000 100% of revenue
Operating costs Derived USD 6.72 million 9,597% of revenue
Operating income −USD 6.65 million −9,497% of revenue
Tax, interest and other Derived USD 1.26 million 1,793% of revenue
Net income −USD 7.9 million −11,290% of revenue

Cash

Operating cash flow −USD 1.32 million −1,887% of revenue
Capital expenditure Unavailable An input is unavailable.
Free cash flow Derived Unavailable An input is unavailable.

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2020 Operating loss: operating costs were 536% of revenue.
2023 Operating loss: operating costs were 9,597% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2020 2020-01-01 – 2020-12-31	1740855	9325589 Derived	-7584734	1917868 Derived	-9502602	Unavailable	Source 2020-01-01 – 2020-12-31: 1740855 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -7584734 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -9502602 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -2812001 USD Inspect Operating Cash Flow Open source
2023 2023-01-01 – 2023-12-31	70000	6718015 Derived	-6648015	1255078 Derived	-7903093	Unavailable	Source 2023-01-01 – 2023-12-31: 70000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -6648015 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -7903093 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -1321047 USD Inspect Operating Cash Flow Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 70K 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Revenue	1740855	Revenue: 1740855 Open source
20232023-12-31	Revenue	70000	Revenue: 70000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Year over year	No prior comparable period	Revenue: 1740855 Open source
20232023-12-31	Year over year	No prior comparable period	Revenue: 70000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -9,497.2% 2023

Net margin -11,290.1% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Operating margin	-435.7%	Operating Income: -7584734 Open source Revenue: 1740855 Open source
20232023-12-31	Operating margin	-9,497.2%	Operating Income: -6648015 Open source Revenue: 70000 Open source
20202020-12-31	Net margin	-545.9%	Net Income: -9502602 Open source Revenue: 1740855 Open source
20232023-12-31	Net margin	-11,290.1%	Net Income: -7903093 Open source Revenue: 70000 Open source
20202020-12-31	Free cash flow margin	Not reported	Revenue: 1740855 Open source Operating Cash Flow: -2812001 Open source
20232023-12-31	Free cash flow margin	Not reported	Revenue: 70000 Open source Operating Cash Flow: -1321047 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -1.3M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Operating cash flow	-2812001	Operating Cash Flow: -2812001 Open source
20232023-12-31	Operating cash flow	-1321047	Operating Cash Flow: -1321047 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20202020-12-31	Free cash flow	Unavailable	Operating Cash Flow: -2812001 Open source
20232023-12-31	Free cash flow	Unavailable	Operating Cash Flow: -1321047 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

61.3% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
2020-12-31	Liabilities / assets	Not reported	Total Assets: 23663205 Open source
20232023-12-31	Liabilities / assets	61.3%	Total Liabilities: 18403415 Open source Total Assets: 30014952 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.02× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20202020-12-31	Current assets / current liabilities	0.06×	Current Assets: 615636 Open source Current Liabilities: 11182372 Open source
20232023-12-31	Current assets / current liabilities	0.02×	Current Assets: 271737 Open source Current Liabilities: 16504947 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2016 2016-01-01 – 2016-12-31	−USD 13.65 million Exact value Exact value: -13654000 USD 2016-01-01 – 2016-12-31: -13654000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2016-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: -13654000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13654000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000119312518191628/oxgn-20180331.xml#409111 Filing: 000119312518191628 The citation records this snapshot. The page link may show a newer release later.	−USD 15.24 million Exact value Exact value: -15238000 USD 2016-01-01 – 2016-12-31: -15238000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2016-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -15238000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -15238000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000119312518191628/oxgn-20180331.xml#408843 Filing: 000119312518191628 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2017 2017-01-01 – 2017-12-31	−USD 13.81 million Exact value Exact value: -13812000 USD 2017-01-01 – 2017-12-31: -13812000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2017-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: -13812000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13812000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000119312519102832/matn-20181231.xml#75609 Filing: 000119312519102832 The citation records this snapshot. The page link may show a newer release later.	−USD 10.93 million Exact value Exact value: -10932000 USD 2017-01-01 – 2017-12-31: -10932000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2017-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -10932000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10932000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000119312519102832/matn-20181231.xml#82475 Filing: 000119312519102832 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2018 2018-01-01 – 2018-12-31	−USD 712,738 Exact value Exact value: -712738 USD 2018-01-01 – 2018-12-31: -712738 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2018-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: -712738 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -712738 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315220008845/matn-20191231.xml#220180 Filing: 000149315220008845 The citation records this snapshot. The page link may show a newer release later.	−USD 240,980 Exact value Exact value: -240980 USD 2018-01-01 – 2018-12-31: -240980 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2018-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -240980 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -240980 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315220008845/matn-20191231.xml#227778 Filing: 000149315220008845 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2019 2019-01-01 – 2019-12-31	−USD 6.64 million Exact value Exact value: -6638013 USD 2019-01-01 – 2019-12-31: -6638013 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2019-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: -6638013 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -6638013 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315221012757/otlc-20210331.xml#356211 Filing: 000149315221012757 The citation records this snapshot. The page link may show a newer release later.	−USD 2.28 million Exact value Exact value: -2280690 USD 2019-01-01 – 2019-12-31: -2280690 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2019-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -2280690 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2280690 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315221012757/otlc-20210331.xml#648241 Filing: 000149315221012757 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2020 2020-01-01 – 2020-12-31	−USD 9.5 million Exact value Exact value: -9502602 USD 2020-01-01 – 2020-12-31: -9502602 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2020-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: -9502602 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9502602 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315222010094/form10-k.htm#2232583 Filing: 000149315222010094 The citation records this snapshot. The page link may show a newer release later.	−USD 2.81 million Exact value Exact value: -2812001 USD 2020-01-01 – 2020-12-31: -2812001 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2020-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -2812001 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -2812001 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315222010094/form10-k.htm#2471508 Filing: 000149315222010094 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2021 2021-01-01 – 2021-12-31	−USD 9.39 million Exact value Exact value: -9391042 USD 2021-01-01 – 2021-12-31: -9391042 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2021-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: -9391042 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9391042 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315223012978/form10-ka.htm#1878813 Filing: 000149315223012978 The citation records this snapshot. The page link may show a newer release later.	−USD 4.43 million Exact value Exact value: -4434465 USD 2021-01-01 – 2021-12-31: -4434465 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2021-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -4434465 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -4434465 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315223012978/form10-ka.htm#2036590 Filing: 000149315223012978 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2022 2022-01-01 – 2022-12-31	USD 5.09 million Exact value Exact value: 5094981 USD 2022-01-01 – 2022-12-31: 5094981 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2022-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: 5094981 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: 5094981 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315224014475/form10-k.htm#1907075 Filing: 000149315224014475 The citation records this snapshot. The page link may show a newer release later.	−USD 1.45 million Exact value Exact value: -1452562 USD 2022-01-01 – 2022-12-31: -1452562 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2022-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -1452562 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1452562 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315224014475/form10-k.htm#2143019 Filing: 000149315224014475 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2023 2023-01-01 – 2023-12-31	−USD 7.9 million Exact value Exact value: -7903093 USD 2023-01-01 – 2023-12-31: -7903093 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2023-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: -7903093 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7903093 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000164117225004846/form10-k.htm#1364264 Filing: 000164117225004846 The citation records this snapshot. The page link may show a newer release later.	−USD 1.32 million Exact value Exact value: -1321047 USD 2023-01-01 – 2023-12-31: -1321047 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2023-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -1321047 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1321047 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000164117225004846/form10-k.htm#1449625 Filing: 000164117225004846 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2024 2024-01-01 – 2024-12-31	−USD 4.52 million Exact value Exact value: -4523932 USD 2024-01-01 – 2024-12-31: -4523932 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2024-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: -4523932 USD Concept: fundies:NetIncome Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:NetIncome: -4523932 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315226016838/form10-k.htm#1799652 Filing: 000149315226016838 The citation records this snapshot. The page link may show a newer release later.	−USD 740,277 Exact value Exact value: -740277 USD 2024-01-01 – 2024-12-31: -740277 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2024-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -740277 USD Concept: fundies:OperatingCashFlow Period: 2024-01-01 to 2024-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2024-12-31&surface=latest&period_type=duration&start=2024-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -740277 USD (2024-01-01 to 2024-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315226016838/form10-k.htm#1971522 Filing: 000149315226016838 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.
2025 2025-01-01 – 2025-12-31	USD 249.3 million Exact value Exact value: 249300000 USD 2025-01-01 – 2025-12-31: 249300000 USD Inspect Net Income Open source Share or cite Citation for Net Income · ONCOTELIC THERAPEUTICS, INC. · 2025-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Net Income: 249300000 USD Concept: fundies:NetIncome Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3ANetIncome&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:NetIncome: 249300000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315226037857/form10-q.htm#639003 Filing: 000149315226037857 The citation records this snapshot. The page link may show a newer release later.	−USD 1.4 million Exact value Exact value: -1400000 USD 2025-01-01 – 2025-12-31: -1400000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · ONCOTELIC THERAPEUTICS, INC. · 2025-12-31 ONCOTELIC THERAPEUTICS, INC. (edgar:908259) Operating Cash Flow: -1400000 USD Concept: fundies:OperatingCashFlow Period: 2025-01-01 to 2025-12-31 Values: Latest reported Published: 2026-11-02T23:23:14Z Snapshot: ca0e640291d283e31cd085dc5f031d4808aa3fcec275282fa6d28a8b9cdc6dad Dimensions: Consolidated View: https://fundies.io/companies/edgar/908259/explain?concept=fundies%3AOperatingCashFlow&period=2025-12-31&surface=latest&period_type=duration&start=2025-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -1400000 USD (2025-01-01 to 2025-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/908259/000149315226016838/form10-k.htm#2059648 Filing: 000149315226016838 The citation records this snapshot. The page link may show a newer release later.	Unavailable Not reported for this period.	Unavailable Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

181 filings · 2,811 latest values · 2,811 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0000908259, 908259, MATN, OTLC, OXGN, edgar:908259

Also known as MATEON THERAPEUTICS INC, ONCOTELIC THERAPEUTICS, INC., OXIGENE INC, Oncotelic Therapeutics, Inc., Oncotelic Therapeutics, Inc.

ONCOTELIC THERAPEUTICS, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Reported share-count change

Trailing twelve months

Net income

Operating cash flow

Company performance

What changed year over year

Net income

Operating cash flow

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation